The parkin V380L variant is a genetic modifier of Machado–Joseph disease with impact on mitophagy
Jonasz Jeremiasz Weber(University Hospitals of the Ruhr-University of Bochum), Guy A. Rouleau(Montreal Neurological Institute and Hospital), Jorge Sequeiros(Universidade do Porto), Roy Zaltzman(Tel Aviv University), Marcondes C. França(National Hospital for Neurology and Neurosurgery), Gunnar Blumenstock(University of Tübingen), Bart P.C. van de Warrenburg(Radboud University Nijmegen), Laura Bannach Jardim(Universidade Federal do Rio Grande do Sul), Sandra Martins(Universidade do Porto), Chrisovalantou Huridou(University of Tübingen), Alexandra Dürr(Centre National de la Recherche Scientifique), Alexis Brice(Inserm), N Schwarz(University of Tübingen), Priscila Pereira Sena(University of Tübingen), Rana Dilara Incebacak Eltemur(University of Tübingen), Daniel Weishäupl(University of Tübingen), Olaf Rieß(University of Tübingen), Lüdger Schöls(German Center for Neurodegenerative Diseases), Miriam Döcker(University of Tübingen), Maria Luiza Saraiva Pereira(Universidade Federal do Rio Grande do Sul), Florian Fath(University of Tübingen), Peter Bauer(Centogene (Germany)), Carlos R. Gordon(Tel Aviv University), Leah Czisch(University of Tübingen), Anna Würth(University of Tübingen), Mario Cornejo‐Olivas(Universidad Científica del Sur), Thomas Klockgether(University Hospital Bonn)
Cited by 8
Related Papers
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
Mortality after surgery in Europe: a 7 day cohort study
|The Lancet|2012|1.4k